CHRISTY KINSEY: Open Payments
NPI 1083083380 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 33 payments from 12 companies in 2025. Trend: 2023 $798 · 2024 $686 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $158 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| Genentech USA, Inc. | 4 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| GENZYME CORPORATION | 3 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| CSL Behring | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Pharming Healthcare, Inc. | 1 | $27 |
| BioCryst US Sales Co., LLC | 1 | $26 |
Products named: DUPIXENT, PANZYGA, Xolair, Rhapsido, TAKHZYRO, CUVITRU, Andembry, AYVAKIT.
Industry payments across TN — which companies pay providers there.
